University of California, San Francisco/Helen Diller Cancer Institute — San Francisco, California

University of California, San Francisco/Helen Diller Cancer Institute is a clinical research site located in San Francisco, California, United States 94115.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California, San Francisco/Helen Diller Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Solid Tumors.

Sponsors: OncoMed Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, San Francisco/Helen Diller Cancer Institute?

University of California, San Francisco/Helen Diller Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, San Francisco/Helen Diller Cancer Institute conducted?

University of California, San Francisco/Helen Diller Cancer Institute has 1 clinical trials on record. Their work covers Relapsed or Refractory Solid Tumors.

Is University of California, San Francisco/Helen Diller Cancer Institute accredited by Crixeo Health?

University of California, San Francisco/Helen Diller Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, San Francisco/Helen Diller Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.